Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | LDHA | P00338 | 1/20 | 0.42 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.41 |
| ▸ | USP2 | O75604 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 1/20 | 0.39 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pivalate SCHEMBL5675628 | 0.90 | CTSK (0.41) | CTSKHTTLDHAEGFR | |
| SCHEMBL5679280 | 0.87 | IDO1 (0.44) | HTTUSP2TP53 | |
| SCHEMBL28712476 | 0.81 | ALDH1A1 (0.44) | CTSKHTT | |
| Pivalate SCHEMBL28335975 | 0.75 | KDM4E (0.62) | KDM4E | |
| SCHEMBL9409911 | 0.74 | SLC22A1 (0.52) | HTTTP53 | |
| Bicarbonate SCHEMBL28308089 | 0.74 | DNM1 (0.51) | HTTTP53POLB | |
| Tetrabuthylammonium SCHEMBL2354515 | 0.73 | SLC22A1 (0.57) | TP53 | |
| Pivalate SCHEMBL18797178 | 0.72 | MAOB (0.54) | HTTLDHACTBP2POLB | |
| Oxalic Acid SCHEMBL27769825 | 0.72 | DNM1 (0.50) | HTTTP53POLB | |
| SCHEMBL26357051 | 0.71 | SLC22A1 (0.37) | HTTTP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7001973-B2 | Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups | DEGUSSA AG (DE) | 2006-02-21 | — | — | US | claimed |
| EP-1229016-B1 | Catalyst and process for the preparation of isocyanate groups containing polyisocyanates with low viscosity and reduced colour | DEGUSSA (DE) | 2006-01-11 | — | — | EP | claimed |
| US-12594700-B2 | Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes | COVESTRO DEUTSCHLAND AG (DE) | 2026-04-07 | — | — | US | disclosed |
| US-20250388778-A1 | POLYISOCYANATE MIXTURE | COVESTRO DEUTSCHLAND AG (DE) | 2025-12-25 | — | — | US | disclosed |
| US-12492281-B2 | Polyisocyanurate materials as electrical potting compounds | COVESTRO DEUTSCHLAND AG (DE) | 2025-12-09 | — | — | US | disclosed |
| EP-4551634-A1 | POLYISOCYANATE MIXTURE | Covestro Deutschland AG (DE) | 2025-05-14 | — | — | EP | disclosed |
| EP-3688050-B1 | TWO-COMPONENT SYSTEM FOR ELASTIC COATINGS | COVESTRO DEUTSCHLAND AG (DE) | 2025-03-26 | — | — | EP | disclosed |
| US-12247144-B2 | Anhydrously curing polyisocyanate-based adhesives | COVESTRO DEUTSCHLAND AG (DE) | 2025-03-11 | — | — | US | disclosed |
| US-12157790-B2 | Composite materials based on dual-cure urethane polymers and dual-cure isocyanurate polymers | COVESTRO INTELLECTUAL PROPERTY GMBH & CO. KG (DE) | 2024-12-03 | — | — | US | disclosed |
| EP-3601405-B1 | GENERATION OF POLYISOCYANURATE LAYERS THROUGH SEPARATE APPLICATION OF ISOCYANATE COMPONENTS AND CATALYSTS | COVESTRO DEUTSCHLAND AG (DE) | 2024-08-28 | — | — | EP | disclosed |
| EP-3743449-B1 | SEMI-FINISHED PRODUCTS BASED ON DUAL CROSS-LINKING MECHANISM | COVESTRO DEUTSCHLAND AG (DE) | 2024-04-17 | — | — | EP | disclosed |
| EP-3286242-A1 | POLYISOCYANURATE PLASTICS HAVING HIGH THERMAL STABILITY | Covestro Deutschland AG (DE) | 2018-02-28 | — | — | EP | disclosed |
| EP-3286244-A1 | POLYISOCYANURATE POLYMERS AND PROCESS FOR THE PRODUCTION OF POLYISOCYANURATE POLYMERS | Covestro Deutschland AG (DE) | 2018-02-28 | — | — | EP | disclosed |
| WO-2016170061-A1 | POLYISOCYANURATE PLASTICS HAVING HIGH THERMAL STABILITY | COVESTRO DEUTSCHLAND AG (DE) | 2016-10-27 | — | — | WO | disclosed |
| WO-2016170060-A1 | PROCESS FOR PRODUCING POLYISOCVANURATE PLASTICS HAVING FUNCTIONALIZED SURFACES | COVESTRO DEUTSCHLAND AG (DE) | 2016-10-27 | — | — | WO | disclosed |
| WO-2016170059-A1 | POLYISOCYANURATE POLYMERS AND PROCESS FOR THE PRODUCTION OF POLYISOCYANURATE POLYMERS | COVESTRO DEUTSCHLAND AG (DE) | 2016-10-27 | — | — | WO | disclosed |
| US-7001973-B2 | Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups | DEGUSSA AG (DE) | 2006-02-21 | — | — | US | disclosed |
| US-20030187178-A1 | Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups | DEGUSSA AG (DE) | 2003-10-02 | — | — | US | disclosed |
| US-6613863-B2 | Benzyltrialkylammonium carboxylate isocyanate trimerization catalysts | DEGUSSA AG (DE) | 2003-09-02 | — | — | US | disclosed |
| US-20020120089-A1 | Catalyst and process for preparing low-viscosity and color-reduced polyisocyanates containing isocyanurate groups | DEGUSSA AG (DE) | 2002-08-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250388778-A1 | POLYISOCYANATE MIXTURE | IPO11, IPO5, ALKBH1 | CTSK 4880/4885HTT 1351/4885LDHA 3702/4885 |
| US-12594700-B2 | Coatings from polyisocyanurate coatings (rim) and their use in injection molding processes | TST, C9, ESD | CTSK 4861/4885HTT 1569/4885LDHA 4145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.